Technetium pyrophosphate myocardial uptake and peripheral neuropathy in a rare variant of familial transthyretin (TTR) amyloidosis (Ser23Asn): A case report and literature review

Amyloid

Volumn 19, Issue 1, 2012, Pages 41-46

  Castaño, Adam ^a   Bokhari, Sabahat ^b   Brannagan, Thomas H ^c   Wynn, Julia ^a   Maurer, Mathew S ^b  

^a Columbia College of Physicians and Surgeons ^*  (United States)

^b Center for Advanced Cardiac Care   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

ATTR; Peripheral neuropathy; Ser23Asn; Technetium pyrophosphate; Transthyretin amyloid

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; PYROPHOSPHATE TECHNETIUM TC 99M; TROPONIN;

ADULT; AMYLOIDOSIS; CASE REPORT; DYSPNEA; ELECTROMYOGRAPHY; FATIGUE; GENE MUTATION; GENOTYPE; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER TRANSPLANTATION; MALE; PERICARDIAL EFFUSION; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; REVIEW; SCINTIGRAPHY; TRANSTHYRETIN AMYLOIDOSIS;

ADULT; AMYLOID NEUROPATHIES, FAMILIAL; CARDIOMYOPATHIES; HEART; HEART TRANSPLANTATION; HUMANS; LIVER TRANSPLANTATION; MALE; MUTATION, MISSENSE; MYOCARDIUM; PEDIGREE; PREALBUMIN; TECHNETIUM TC 99M PYROPHOSPHATE;

EID: 84857219942     PISSN: 13506129     EISSN: 17442818     Source Type: Journal    
DOI: 10.3109/13506129.2011.638682     Document Type: Review

References (29)

1. Benson MD. Amyloidosis. In: Scriver CR, Beaudet AK, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. 7th ed. New York: McGraw-Hill; 1995. pp 4159-4191
2. Lachmann HJ, Booth DR, Booth SE, Bybee A, Gilbertson JA, Gillmore JD, Pepys MB, Hawkins PN. Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis. N Engl J Med 2002;346:1786-1791. (Pubitemid 34586914)
3. Robbins J. Thyroxine-binding proteins. Prog Clin Biol Res 1976;5:331-355.
4. Connors LH, Richardson AM, Th?erge R, Costello CE. Tabulation of transthyretin (TTR) variants as of 1/1/2000. Amyloid 2000;7:54-69. (Pubitemid 30317630)
5. Benson MD. Amyloidosis. In: Scriver CR, Beaudet, AK, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited diseases. 8th ed. New York: McGraw-Hill; 2001. pp 5345-5378
6. Saraiva MJ. Transthyretin mutations in hyperthyroxinemia and amyloid diseases. Hum Mutat 2001;17:493-503. (Pubitemid 32480084)
7. Liepnieks JJ, Benson MD. Progression of cardiac amyloid deposition in hereditary transthyretin amyloidosis patients after liver transplantation. Amyloid 2007;14:277-282. (Pubitemid 350035574)
8. Connors LH, Th?erge R, Skare J, Costello CE, Falk RH, Skinner M. A new transthyretin variant (Ser23Asn) associated with familial amyloidosis in a Portuguese patient. Amyloid 1999;6:114-118. (Pubitemid 29362033)
9. Mueller I, Gawaz M, Linke R, Zuern C, Steiner D, Altland K, Von Beckerath N, Weig H. Restrictive cardiomyopathy in inherited ATTR amyloidosis (TT-Ser23Asn) in a patient of German-Italian extraction. BMJ Case Reports [serial on the Internet]. 2010.
10. Daoko J, Elnahar Y, El Kersh K, Mohammad N, Shamoon F. Cardiac MRI detection of a rare case of familial cardiac amyloidosis (Ser23Asn): Case report with literature review. Rep MedImag 2010;3:123-127.
11. Sekijima Y, Dendle MA, Kelly JW. Orally administered diflunisal stabilizes transthyretin against dissociation required for amyloidogenesis. Amyloid 2006;13:236-249. (Pubitemid 44764463)
12. Bispo M, Marcelino P, Freire A, Martins A, Mourao L, Barroso E. High incidence of thrombotic complications early after liver transplantation for familial amyloidotic polyneuropathy. Transpl Int 2009;22:165-171.
13. Sharma P, Perri RE, Sirven JE, Zeldenrust SR, Brandhagen DJ, Rosen CB, Douglas DD, et al. Outcome of liver transplantation for familial amyloidotic polyneuropathy. Liver Transpl 2003;9:1273-1280. (Pubitemid 37536798)
14. Liepnieks JJ, Zhang LQ, Benson MD. Progression of transthyretin amyloid neuropathy after liver transplantation. Neurology 2010;75:324-327.
15. Bergethon PR, Sabin TD, Lewis D, Simms RW, Cohen AS, Skinner M. Improvement in the polyneuropathy associated with familial amyloid polyneuropathy after liver transplantation. Neurology 1996;47:944-951.
16. Said G, Ropert A, Faux N. Length-dependent degeneration of fibers in Portuguese amyloid polyneuropathy: A clinicopathologic study. Neurology 1984;34:1025-1032. (Pubitemid 14094240)
17. Carvalho J, Coimbra A, Andrade C. Peripheral nerve fibre changes in asymptomatic children of patients with familial amyloid polyneuropathy. Brain 1976;99:1-10.
18. Coimbra A, Andrade C. Familial amyloid polyneuropathy: An electron microscope study of the peripheral nerve in five cases. I. Interstitial changes. Brain 1971;94:199-206.
19. Thomas PK, King RH. Peripheral nerve changes in amyloid neuropathy. Brain 1974;97:395-406.
20. Dyck PJ, Lambert EH. Dissociated sensation in amylidosis. Compound action potential, quantitative histologic and teased-fiber, and electron microscopic studies of sural nerve biopsies. Arch Neurol 1969;20:490-507.
21. Kernohan J, Woltman H. Amyloid neuritis. Archives of Neurology 1942;47:132-140.
22. Kelly J, Lansbury PJ. A chemical approach to elucidate the mechanisms of transthyretin and B-protein amyloid fibril formation. Amyloid 1994;1:186-205. (Pubitemid 2152062)
23. Sabin TD. Classification of peripheral neuropathy: The long and the short of it. Muscle Nerve 1986;9:711-719.
24. Ochs S, Brimijoin A. Axonal transport. In: Dyck Pea, editor. Peripheral Neuropathy. Philadelphia: WB Saunders; 1993. pp 331-360.
25. Glaudemans AW, Slart RH, Zeebregts CJ, Veltman NC, Tio RA, Hazenberg BP, Dierckx RA. Nuclear imaging in cardiac amyloidosis. Eur J Nucl Med Mol Imaging 2009;36:702-714.
26. Wizenberg TA, Muz J, Sohn YH, Samlowski W, Weissler AM. Value of positive myocardial technetium-99m-pyrophosphate scintigraphy in the noninvasive diagnosis of cardiac amyloidosis. Am Heart J 1982;103:468-473. (Pubitemid 13137994)
27. Schiff S, Bateman T, Moffatt R, Davidson R, Berman D. Diagnostic considerations in cardiomyopathy: Unique scintigraphic pattern of diffuse biventricular technetium-99m-pyrophosphate uptake in amyloid heart disease. Am Heart J 1982;103:562-563. (Pubitemid 13138006)
28. Sobol SM, Brown JM, Bunker SR, Patel J, Lull RJ. Noninvasive diagnosis of cardiac amyloidosis by technetium-99m-pyrophosphate myocardial scintigraphy. Am Heart J 1982;103:563-566. (Pubitemid 13138007)
29. Willerson JT, Parkey RW, Bonte FJ, Lewis SE, Corbett J, Buja LM. Pathophysiologic considerations and clinicopathological correlates of technetium-99m stannous pyrophosphate myocardial scintigraphy. Semin Nucl Med 1980;10:54-69. (Pubitemid 10103751)